Leerink Partners analyst Mike Kratky maintained a Buy rating on Tandem Diabetes Care (TNDM – Research Report) on November 25 and set a price ...

We recently compiled a list of the 10 Oversold Healthcare Stocks To Invest In. In this article, we are going to take a look ...

has announced its donation of several insulin pumps to children with type 1 diabetes who are receiving treatment at the Diabetes Clinic in Salmaniya Medical Complex, part of the government hospitals.

Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a medical device company specializing in diabetes management products, has been making waves in the insulin pump market with its recent product launches and ...

Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.

Even though pump therapy may increase the costs associated ... although it may provide a more precise tool for insulin therapy, avoiding frequent injections in very young children.

Nov 7(Reuters) - Insulet (PODD.O), opens new tab raised its annual revenue growth forecast on Thursday, banking on strong demand for its wearable insulin pumps. Shares of the medical device maker ...

Bernstein launched the coverage of insulin pump makers Tandem Diabetes Care (NASDAQ:TNDM) and Insulet Corporation (NASDAQ:PODD) with outperform recommendations just as the duo prepares to release ...

Tandem Mobi is pioneering a new category of insulin pumps, and market awareness is building as the diabetes community has increasing exposure to our new platform. Turning to our performance ...